Thus, in line with our finding that sGC stimulation by NO decreases the expression and activity of TRPC6 during Adriamycin-mediated podocyte injury in vitro, the absence of NO leads to enhanced glomerular TRPC6 expression in a mouse strain normally resistant to Adriamycin-induced nephropathy. The gene discussed is SGCB; the disease is kidney disorder.